Ra. Nowak et al., PRODUCTION OF PROLACTIN BY SMOOTH-MUSCLE CELLS CULTURED FROM HUMAN UTERINE FIBROID TUMORS, The Journal of clinical endocrinology and metabolism, 76(5), 1993, pp. 1308-1313
Uterine leiomyomas, which are myometrial smooth muscle tumors, secrete
PRL. We investigated the actions of several hormones known to stimula
te PRL secretion by the pituitary gland or decidua on PRL secretion by
leiomyoma-derived smooth muscle cells (SMC) in monolayer culture. Cul
tures were verified to be SMC by immunostaining for smooth muscle alph
a-actin and desmin. Hormone treatments were performed in serum-free me
dium for 72 h. Medium was harvested every 24 h and assayed for PRL. 17
beta-Estradiol, progesterone, TRH, insulin-like growth factor-I, epide
rmal growth factor, and the GnRH agonist leuprolide did not affect PRL
secretion by these SMC. Insulin caused a significant suppression of P
RL secretion by 72 h, and this was accompanied by a 64% increase in to
tal cell protein per well, which represented an increase in cell numbe
r. Cells were also plated at various densities to determine the effect
s of cell number on PRL secretion. The amount of PRL secreted per 1000
cells decreased significantly as cell number per well increased. Nort
hern blot analysis identified PRL mRNA in fresh leiomyoma tissue. PRL
mRNA in three independent cultures of SMC was then detected by reverse
transcription and the polymerase chain reaction. Hybridization occurr
ed only with the expected band of approximately 423 basepairs in size.
We conclude that leiomyomas express PRL mRNA in vivo and that leiomyo
ma-derived SMC in culture continue to express the PRL mRNA and secrete
PRL in the absence of ovarian steroids. PRL secretion by SMC in cultu
re appears to be modulated primarily by changes in cell density.